- Home
- SNY vs CRWD Comparison
SNY vs CRWD Comparison
Compare SNY & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNY | CRWD |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8B | 118.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SNY | CRWD |
|---|---|---|
| Price | $44.49 | $427.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 47 |
| Target Price | $61.50 | ★ $506.68 |
| AVG Volume (30 Days) | 4.2M | ★ 4.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | $2.62 | $24.25 |
| Revenue Next Year | $6.38 | $21.37 |
| P/E Ratio | $6.14 | ★ N/A |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $44.62 | $298.14 |
| 52 Week High | $60.12 | $566.90 |
Technical Indicators
Market Signals| Indicator | SNY | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 55.98 |
| Support Level | N/A | $409.09 |
| Resistance Level | $48.97 | $442.00 |
| Average True Range (ATR) | 0.70 | 22.55 |
| MACD | -0.29 | 7.38 |
| Stochastic Oscillator | 8.84 | 95.52 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.